Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1990 Oct 15;143(8):747–749.

Porphyria cutanea tarda due to ferrous gluconate.

A D Ginsburg 1, L J Margesson 1, K Feleki 1
PMCID: PMC1452374  PMID: 2207938

Full text

PDF
747

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elder G. H., Urquhart A. J., De Salamanca R. E., Munoz J. J., Bonkovsky H. L. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet. 1985 Aug 3;2(8449):229–233. doi: 10.1016/s0140-6736(85)90287-9. [DOI] [PubMed] [Google Scholar]
  2. Grossman M. E., Bickers D. R., Poh-Fitzpatrick M. B., Deleo V. A., Harber L. C. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med. 1979 Aug;67(2):277–286. doi: 10.1016/0002-9343(79)90403-0. [DOI] [PubMed] [Google Scholar]
  3. Ramsay C. A., Magnus I. A., Turnbull A., Baker H. The treatment of porphyria cutanea tarda by venesection. Q J Med. 1974 Jan;43(169):1–24. [PubMed] [Google Scholar]
  4. Sweeney G. D., Jones K. G. Porphyria cutanea tarda: clinical and laboratory features. Can Med Assoc J. 1979 Apr 7;120(7):803–807. [PMC free article] [PubMed] [Google Scholar]
  5. Sweeney G. D. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. Clin Biochem. 1986 Feb;19(1):3–15. doi: 10.1016/s0009-9120(86)80064-9. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES